What is INDP stock price today?

INDP (Indaptus Therapeutics Inc) stock is trading at $2.71 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is INDP stock going up or down today?

INDP stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy INDP stock now?

The decision to buy INDP depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is INDP a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for INDP based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is INDP stock overvalued or undervalued?

Use our DCF valuation calculator to determine if INDP is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is INDP's P/E ratio?

P/E ratio data for INDP will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is INDP's market cap?

INDP (Indaptus Therapeutics Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is INDP's price to book ratio?

INDP trades at a price-to-book (P/B) ratio of 1.51, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does INDP pay dividends?

INDP does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is INDP's dividend yield?

INDP does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is INDP stock a good long-term investment?

INDP's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is INDP's revenue growth rate?

Revenue growth data for INDP is available on our dashboard with detailed financial statement analysis.

Profitability metrics for INDP are available on our dashboard with complete income statement analysis.

What are the risks of investing in INDP?

Key risks for INDP include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does INDP compare to its competitors?

Compare INDP to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize INDP's performance and positioning.

What is INDP's stock price target for 2026?

Our AI model provides price targets for INDP based on fundamental analysis: Bull case $3.52 (+30%), Base case $3.12 (+15%), Bear case $2.44 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about INDP?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for INDP. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is INDP's next earnings report?

INDP reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

INDP - Indaptus Therapeutics Inc

NYSE * Health Care * Biotechnology

$2.71

+$0.38 (+16.31%)

About Indaptus Therapeutics Inc

Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.

INDP Key Statistics

Market Cap

$4.62M

P/B Ratio

1.51

EPS

$-21.58

Employees

How INDP Compares to Peers

INDP is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
INDP(This stock)	$4.62M	N/A	0%	0.0%	-
AMGNAmgen Inc	$189.19B	24.7	0%	0.2%	vs AMGN
GILDGilead Sciences	$174.33B	20.7	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.01B	29.0	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.87B	18.2	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.50B	20.5	-0%	0.1%	vs BIIB

Indaptus Therapeutics Inc Company Information

Headquarters: Israel
Website: indaptusrx.com
Sector: Health Care
Industry: Biotechnology

Data Updated: April 16, 2026 at 5:54 PM EDT

Ready to invest in INDP?

Commission-free trading available. Affiliate links.

INDP Lician Score

5% confidence

4.0/10

Neutral

INDP has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates INDPacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

INDP Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for INDP

Dashboard

Enter a ticker to analyze